Pluri Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pluri Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-06-30 was $0.00.
- Pluri Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-03-31 was $0.00.
- Pluri Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $0.00.
- Pluri Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $8.00K.
- Pluri Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $8.00K, a 80.95% decline from fiscal 2018.
- Pluri Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $42.00K, a 320.00% increase from fiscal 2017.
- Pluri Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $10.00K, a 41.18% decline from fiscal 2016.
- Pluri Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $17.00K, a 54.55% increase from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $8.00K 10-K · filed 2020-09-10 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | |
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $42.00K 10-K · filed 2020-09-10 | |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $10.00K 10-K · filed 2019-09-12 |
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $17.00K 10-K · filed 2018-09-12 |
| 2016-03-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | |
| 2015-06-30 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $11.00K 10-K · filed 2017-09-07 |
| 2015-03-31 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | |
| 2014-06-30 | $12.00K 10-K · filed 2016-09-07 | |
| 2013-06-30 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $176.00K 10-K · filed 2013-09-11 |
| 2013-03-31 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $244.00K derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $234.99K derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-09-30 | $146.00K 10-Q · filed 2013-11-05 | $227.00K derived: sum of 4 quarters · filed 2013-11-05 |
| 2012-06-30 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $89.00K 10-K · filed 2013-09-11 |
| 2012-03-31 | $13.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $36.00K derived: sum of 4 quarters · filed 2013-09-11 |
| 2011-12-31 | -$7.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | |
| 2011-09-30 | $8.00K 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $68.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |